Blackstone Valley Community Health Care: drugs

Schedule G of this filing lists 54 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.

The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.

All 54 drug rows

Schedule G as filed, for Blackstone Valley Community Health Care: 54 drugs, in the order filed
LineDrugAmount as filedClaims as filed
1Ozempic169418113, 169413013, 169477212508,090.64 (Schedule G, line 1, page 8 of the filing PDF)583
2Jardiance597015230, 597015290, 597015330
1 more597015390
441,945.42 (Schedule G, line 2, page 8 of the filing PDF)401
3Trulicity00002-1434-80, 2143380, 2223680
1 more2318280
208,081.14 (Schedule G, line 3, page 8 of the filing PDF)198
4Lantus Solostar 100 units/mL SOPN88222033, 88221905173,895.41 (Schedule G, line 4, page 8 of the filing PDF)560
5Farxiga tabs310621030, 310621090, 310620530
1 more310620590
173,518.31 (Schedule G, line 5, page 8 of the filing PDF)206
6Januvia tablets00006027731, 6027754, 00006022131
3 more6022154, 6011231, 6011254
129,158.56 (Schedule G, line 6, page 8 of the filing PDF)163
7Eliquis tabs3089321, 308942197,349.06 (Schedule G, line 7, page 8 of the filing PDF)127
8Basaglar KwikPen SOPN00002-7715-59Listed by the FDA as Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company49,427.30 (Schedule G, line 8, page 8 of the filing PDF)151
9Mounjaro2147180, 2150680,214848044,721.96 (Schedule G, line 9, page 8 of the filing PDF)43
10Vivitrol 380 mg SUSR65757030001Listed by the FDA as VivitrolnaltrexonekitAlkermes, Inc.43,382.12 (Schedule G, line 10, page 8 of the filing PDF)29
11Xarelto 20 mg tabs50458057990Listed by the FDA as Xareltorivaroxaban20 mgtablet, film coatedJanssen Pharmaceuticals, Inc.39,623.52 (Schedule G, line 11, page 8 of the filing PDF)42
12Viagra tabs69422030, 58151042893, 6942103037,293.10 (Schedule G, line 12, page 8 of the filing PDF)28
13Dapagliflozin Propanediol tabs66993045630, 6699304573036,497.74 (Schedule G, line 13, page 8 of the filing PDF)206
14Skyrizi pen 150 mg/mL (1 mL)00074210001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.34,645.33 (Schedule G, line 14, page 8 of the filing PDF)fewer than 6 (the count is not shown)
15Tradjenta 5 mg tabs597014030, 59701409033,445.99 (Schedule G, line 15, page 8 of the filing PDF)37
16Invokana tabs50458014030, 50458014090, 5045801413029,287.20 (Schedule G, line 16, page 8 of the filing PDF)22
17Ocrevus 300 mg/10 mL SDV50242015001Listed by the FDA as Ocrevusocrelizumab300 mg/10 mLinjectionGenentech, Inc.27,387.60 (Schedule G, line 17, page 8 of the filing PDF)fewer than 6 (the count is not shown)
18Actemra inj ACTPen50242-0143-01Listed by the FDA as Actemra ACTPentocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc.27,118.84 (Schedule G, line 18, page 8 of the filing PDF)11
19Tremfya inj 100 mg/mL57894-0640-11Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.26,490.20 (Schedule G, line 19, page 8 of the filing PDF)6
20Genvoya tab61958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc.25,826.59 (Schedule G, line 20, page 8 of the filing PDF)10
21Shingrix 50 mcg/0.5 mL SUSR58160082311Listed by the FDA as Shingrixzoster vaccine recombinant, adjuvantedkitGlaxoSmithKline Biologicals SA22,255.41 (Schedule G, line 21, page 8 of the filing PDF)134
22Humalog KwikPen SOPN2879959, 287975920,985.38 (Schedule G, line 22, page 8 of the filing PDF)30
23Paxlovid standard dose 300/100 mg T00069-5045-30, 00069-5321-3020,688.72 (Schedule G, line 23, page 8 of the filing PDF)21
24Symtuza tablets59676080030Listed by the FDA as Symtuzadarunavir, cobicistat, emtricitabine, and tenofovir alafenamide800 mg; 150 mg; 200 mg; 10 mgtablet, film coatedJanssen Products LP20,426.83 (Schedule G, line 24, page 8 of the filing PDF)6
25Freestyle Libre 2 Sensor MISC5759908000019,095.20 (Schedule G, line 25, page 8 of the filing PDF)100
26Accu-Chek Guide test STRP65702071110, 6570207121017,185.84 (Schedule G, line 26, page 8 of the filing PDF)389
27Trelegy Ellipta 100-62.5-25 AEPB17308871016,154.66 (Schedule G, line 27, page 8 of the filing PDF)17
28Apretude ER inj susp49702026423Listed by the FDA as ApretudecabotegravirkitViiV Healthcare Company15,794.70 (Schedule G, line 28, page 8 of the filing PDF)fewer than 6 (the count is not shown)
29Victoza 18 mg/3 mL SOPN169406012, 16940601313,926.86 (Schedule G, line 29, page 8 of the filing PDF)18
30Linzess 145 mcg caps45612013013,466.47 (Schedule G, line 30, page 8 of the filing PDF)10
31Albuterol Sulfate HFA 108 AERS66993001968, 6818009630112,008.38 (Schedule G, line 31, page 8 of the filing PDF)357
32Medroxyprogesterone Acetat 150 susp66993037025Listed by the FDA as Medroxyprogesterone Acetate150 mg/mLinjection, suspensionPrasco Laboratories11,739.41 (Schedule G, line 32, page 8 of the filing PDF)289
33Biktarvy tablets61958-2501-01Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.11,324.90 (Schedule G, line 33, page 8 of the filing PDF)fewer than 6 (the count is not shown)
34Toujeo Solostar 300 units/mL SOPN2458690310,898.55 (Schedule G, line 34, page 8 of the filing PDF)12
35Symbicort 160-4.5 mcg/ACT aero18603702010,897.99 (Schedule G, line 35, page 8 of the filing PDF)29
36Atorvastatin Calcium tabs60505258008, 6050525800910,856.33 (Schedule G, line 36, page 8 of the filing PDF)777
37Humulin KwikPen SUPN288035910,027.37 (Schedule G, line 37, page 8 of the filing PDF)18
38Tivicay 50 mg tablets49702022813Listed by the FDA as Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company9,865.71 (Schedule G, line 38, page 8 of the filing PDF)9
39Rybelsus 14 mg tabs1694314309,126.35 (Schedule G, line 39, page 8 of the filing PDF)6
40Buprenorphine HCl-Naloxon 12-3 film3788768938,878.37 (Schedule G, line 40, page 8 of the filing PDF)13
41Ubrelvy 50 mg tabs236498108,792.47 (Schedule G, line 41, page 8 of the filing PDF)9
42Dexcom G7 Sensor MISC86270077018,755.41 (Schedule G, line 42, page 8 of the filing PDF)72
43Juluca tab 50-25 mg49702-0242-13Listed by the FDA as Julucadolutegravir sodium and rilpivirine hydrochloride50 mg; 25 mgtablet, film coatedViiV Healthcare Company7,478.37 (Schedule G, line 43, page 8 of the filing PDF)fewer than 6 (the count is not shown)
44Arnuity Ellipta T AEPB1730874107,181.55 (Schedule G, line 44, page 8 of the filing PDF)18
45Budesonide/FORM00310737020Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP6,951.19 (Schedule G, line 45, page 8 of the filing PDF)56
46Novolog Flexpen 100 units/mL SOPN1696339106,656.14 (Schedule G, line 46, page 8 of the filing PDF)23
47Belbuca buccal film59385002760Listed by the FDA as Belbucabuprenorphine hydrochloride900 mcgfilm, solubleBioDelivery Sciences International Inc6,556.67 (Schedule G, line 47, page 8 of the filing PDF)21
48Myrbetriq 50 mg TB244692602306,147.28 (Schedule G, line 48, page 8 of the filing PDF)6
49Tetracycline HCl 500 mg caps23155076701, 60219152301, 621350266015,961.90 (Schedule G, line 49, page 8 of the filing PDF)49
50Janumet tabs60577615,494.84 (Schedule G, line 50, page 8 of the filing PDF)7
51Breo Ellipta AEPB1730882105,455.98 (Schedule G, line 51, page 8 of the filing PDF)14
52Entresto tab00078-0777-20, 00078-0777-675,424.49 (Schedule G, line 52, page 8 of the filing PDF)14
53Insulin Lispro SOPN28222595,384.84 (Schedule G, line 53, page 8 of the filing PDF)55
54Descovy tab61958-2002-01Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.5,099.62 (Schedule G, line 54, page 8 of the filing PDF)fewer than 6 (the count is not shown)
Total Prescription Drugs individually under $5,000631,129.92 (Schedule G, row for amounts under $5,000, page 8 of the filing PDF)34,314 (Schedule G, claims on the row for amounts under $5,000, page 8 of the filing PDF)
Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement3,195,260.14 (Schedule G, printed total, page 8 of the filing PDF)39,738 (Schedule G, printed claims total, page 8 of the filing PDF)

What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.

Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.

Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.

“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. 18 of the 54 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched

Source

Filing PDF
Open Schedule G on the State of Rhode Island's website
SHA-256
eeeeb9fac3107ae365949d2061132412bc18f6fbd9d5fd3f7bcabc7895e88104
Retrieved
11 November 2026
Pages used
8 of 10